Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study
- PMID: 24671110
- DOI: 10.5551/jat.19356
Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study
Abstract
Aim: The Framingham risk score (FRS) is one of the standard tools used to predict the incidence of coronary heart disease (CHD). No previous study has investigated its efficacy for a Japanese population cohort. The purpose of this study was to develop new coronary prediction algorithms for the Japanese population in the manner of the FRS, and to compare them with the original FRS.
Methods: Our coronary prediction algorithms for Japanese were based on a large population-based cohort study (Suita study). The study population comprised 5,521 healthy Japanese. They were followed-up for 11.8 years on average, and 213 cases of CHD were observed. Multiple Cox proportional hazard model by stepwise selection was used to construct the prediction model.
Results: Our coronary prediction algorithms for Japanese patients were based on a large populationbased cohort study (the Suita study). A multiple Cox proportional hazard model by stepwise selection was used to construct the prediction model. The C-statistics showed that the new model had better accuracy than the original and recalibrated Framingham scores. The net reclassification improvement (NRI) by the Suita score with the inclusion of CKD was 41.2% (P<0.001) compared with the original FRS. The recalibration of the FRS slightly improved the efficiency of the prediction, but it was still worse than the Suita score with the CKD model. The calibration analysis suggested that the original FRS and the recalibrated FRS overestimated the risk of CHD in the Japanese population. The Suita score with CKD more accurately predicted the risk of CHD.
Conclusion: The FRS and recalibrated FRS overestimated the 10-year risk of CHD for the Japanese population. A predictive score including CKD as a coronary risk factor for the Japanese population was more accurate for predicting CHD than the original Framingham risk scores in terms of the C-statics and NRI.
Similar articles
-
New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population.Sci Rep. 2019 Feb 26;9(1):2813. doi: 10.1038/s41598-019-39049-w. Sci Rep. 2019. PMID: 30808962 Free PMC article.
-
Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan.J Atheroscler Thromb. 2020 Nov 1;27(11):1160-1175. doi: 10.5551/jat.48843. Epub 2020 Feb 6. J Atheroscler Thromb. 2020. PMID: 32023562 Free PMC article.
-
Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.Int J Cardiol. 2014 Feb 15;171(3):390-7. doi: 10.1016/j.ijcard.2013.12.019. Epub 2013 Dec 23. Int J Cardiol. 2014. PMID: 24388541
-
Assessment of claims of improved prediction beyond the Framingham risk score.JAMA. 2009 Dec 2;302(21):2345-52. doi: 10.1001/jama.2009.1757. JAMA. 2009. PMID: 19952321 Review.
-
Systematic Review of Cardiovascular Disease Risk Assessment Tools [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May. Report No.: 11-05155-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May. Report No.: 11-05155-EF-1. PMID: 21796824 Free Books & Documents. Review.
Cited by
-
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us.Ther Adv Endocrinol Metab. 2022 Nov 22;13:20420188221139101. doi: 10.1177/20420188221139101. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 36439029 Free PMC article. Review.
-
Multicentre, open-label, randomised controlled clinical trial to assess the efficacy and safety of appropriate target values for lipid management in patients who have mild-to-moderate stenotic lesions with high-risk plaques in coronary arteries: study protocol.BMJ Open. 2019 Jan 25;9(1):e022843. doi: 10.1136/bmjopen-2018-022843. BMJ Open. 2019. PMID: 30782687 Free PMC article.
-
Primary Prevention of Coronary and Other Cardiovascular Diseases: A Focused Review.J Atheroscler Thromb. 2024 Aug 1;31(8):1113-1128. doi: 10.5551/jat.RV22019. Epub 2024 Jun 1. J Atheroscler Thromb. 2024. PMID: 38825504 Free PMC article. Review.
-
Hepatokine leukocyte cell-derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction-associated steatotic liver disease in the general population.J Diabetes Investig. 2025 Feb;16(2):298-308. doi: 10.1111/jdi.14351. Epub 2024 Nov 21. J Diabetes Investig. 2025. PMID: 39570764 Free PMC article.
-
Practical Cutoff Values of Brachial-Ankle Pulse Wave Velocity to Predict 10-Year CHD Risk in the Japanese General Population.J Atheroscler Thromb. 2023 May 1;30(5):437-439. doi: 10.5551/jat.ED215. Epub 2022 Oct 1. J Atheroscler Thromb. 2023. PMID: 36184559 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources